nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

10.12.2016 | Head and Neck

Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol

verfasst von: Gorkem Eskiizmir, Gokce Tanyeri Toker, Onur Celik, Kivanc Gunhan, Ayca Tan, Hulya Ellidokuz

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

The prognosis is suboptimal in patients with locoregionally advanced laryngeal carcinoma even after multimodality protocols. The purpose of this study was to determine the potential influential factors that have an impact on the development of locoregional recurrence, distant metastasis, and oncological outcomes in patients with locoregionally advanced laryngeal carcinoma who had surgical multimodality protocols. A sample size of 85 cases was determined based on a power of 90% and an effect size of α ₂ = 0.05. A retrospective analysis of 357 patients with a diagnosis of laryngeal cancer between 2002 and 2015 was performed. Eighteen variables based on sociodemographic, clinical, histopathological and treatment data were analyzed. Medical records of 85 consecutive patients with locoregionally advanced laryngeal carcinoma who underwent surgical multimodality protocols were reviewed. Five-year overall, disease-specific, disease-free, locoregional recurrence-free and distant metastasis-free survival were 68.7, 78.0, 69.6, 68.9 and 69.2%, respectively. Extracapsular extension was an independent predictive factor for locoregional recurrence. Pathologic tumor volume was an independent predictive factor for distant metastasis. pT-stage was an independent prognostic factor for 5-year overall survival, disease-free survival, locoregional recurrence-free survival and distant metastasis-free survival. High volume, pT4a laryngeal tumors with extracapsular extension are associated with a high risk of locoregional recurrence and distant metastasis; and have poor oncological outcomes in patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocols.

Nur mit Berechtigung zugänglich

Rudolph E, Dyckhoff G, Becher H, Dietz A, Ramroth H (2011) Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 268:165–179CrossRefPubMed

BC Cancer Statistics (Internet). British Columbia: BC Cancer Agency; 2013.http://www.bccancer.bc.ca/HPI/CancerStatistics/FF/cancercases.htm. Accessed 26 Apr 2013

Bussu F, Miccichè F, Rigante M et al (2012) Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases. Head Neck 34:573–579CrossRefPubMed

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249CrossRefPubMed

Hoffman HT, Porter K, Karnell LH et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116:1–13CrossRefPubMed

Teknos TN, Hogikyan ND, Wolf GT (2001) Conversation laryngeal surgery for malignant tumors of the larynx and pyriform sinus. Hematol Oncol Clin N Am 15:261–276CrossRefPubMed

Pfister D, Laurie S, Weinstein G et al (2006) American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693–3704CrossRefPubMed

Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685–1690CrossRef

Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899CrossRefPubMed

10.

Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098CrossRefPubMed

11.

Chen AY, Schrag N, Hao Y et al (2006) Changes in treatment of advanced laryngeal cancer 1985–2001. Otolaryngol Head Neck Surg 135:831–837CrossRefPubMed

12.

Chen AY, Fedewa S (2011) Temporal trends in the treatment of early and advanced-stage laryngeal cancer in the United States, 1985–2007. Arch Otolaryngol Head Neck Surg 137:1017–1024CrossRefPubMed

13.

Timmermans AJ, de Gooijer CJ, Hamming-Vrieze O, Hilgers FJ, van den Brekel MW (2015) T3–T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol. Head Neck 37:1495–1503CrossRefPubMed

14.

MacKenzie RG, Franssen E, Balogh JM et al (2000) Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 47:65–71CrossRefPubMed

15.

Timmermans AJ, van Dijk BA, Overbeek LI et al (2016) Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands. Head Neck 38:1247–1255CrossRef

16.

Sano H, Hamashima C (2005) Comparison of laryngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960–2000). Jpn J Clin Oncol 35:626–629CrossRefPubMed

17.

Machtay M, Moughan J, Trotti A et al (2008) Factor associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589CrossRefPubMedPubMedCentral

18.

Cosetti M, Yu GP, Schantz SP (2008) Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 134:370–379CrossRefPubMed

19.

Gourin CG, Dy SM, Herbert RJ et al (2014) Treatment, survival, and costs of laryngeal cancer care in the elderly. Laryngoscope 124:1827–1835CrossRefPubMed

20.

Misono S, Marmor S, Yueh B, Virnig BA (2014) Treatment and survival in 10.249 patients with localized laryngeal cancer: a population-based analysis. Cancer 120:1810–1817CrossRefPubMed

21.

Van Dijk BA, Karim-Kos HE, Coebergh JW, Marres HA, de Vries E (2014) Progress against laryngeal cancer in The Netherlands between 1989 and 2010. Int J Cancer 134:674–681CrossRefPubMed

22.

MacNeil SD, Liu K, Shariff SZ et al (2015) Secular trends in the survival of patients with laryngeal carcinoma, 1995-2007. Curr Oncol 22:85–99CrossRef

23.

Altundag O, Gullu I, Altundag K et al (2005) Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck 27:15–21CrossRefPubMed

24.

Megwalu UC, Sikora AG (2014) Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg 140:855–860CrossRefPubMed

25.

Woo JS, Baek SK, Kwon SY, Jung KY, Lee J (2003) T3 supraglottic cancer: treatment results and prognostic factors. Acta Otolaryngol 123:980–986CrossRefPubMed

26.

Qian W, Zhu G, Wang Y et al (2014) Multi-modality management for loco-regionally advanced laryngeal and hypopharyngeal cancer: balancing the benefit of efficacy and functional preservation. Med Oncol 31:178CrossRefPubMed

27.

O’Neill CB, O’Neill JB, Atoria CL et al (2014) Treatment complications and survival in advanced laryngeal cancer: a population-based analysis. Laryngoscope 124:2707–2713CrossRefPubMedPubMedCentral

28.

Rosenthal DI, Mohamed AS, Weber RS et al (2015) Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey. Cancer 121:1608–1619CrossRefPubMedPubMedCentral

29.

Dziegielewski PT, O’Connell DA, Klein M et al (2012) Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg 41(Suppl 1):S56–S64PubMed

30.

Grover S, Swisher-McClure S, Mitra N et al (2015) Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol Biol Phys 92:594–601CrossRefPubMed

31.

Timme DW, Jonnalagadda S, Patel R, Rao K, Robbins KT (2015) Treatment selection for T3/T4a laryngeal cancer: chemoradiation versus primary surgery. Ann Otol Rhinol Laryngol 124:845–851CrossRefPubMed

32.

Francis E, Matar N, Khoueir N et al (2014) T4a laryngeal cancer survival: retrospective institutional analysis and systematic review. Laryngoscope 124:1618–1623CrossRefPubMed

33.

Laramore GE, Scott CB, al-Sarraf M et al (1992) Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23:705–713CrossRefPubMed

34.

Nicolai P, Redaelli de Zinis LO, Tomenzoli D et al (1997) Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 19:323–334CrossRefPubMed

35.

Ganly I, Patel SG, Matsuo J et al (2009) Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 31:1489–1495CrossRefPubMed

36.

Almadori G, Bussu F, Cadoni G et al (2005) Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological appproach. Eur J Cancer 41:683–693CrossRefPubMed

37.

Matsuo JM, Patel SG, Singh B et al (2003) Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 238:412–421PubMedPubMedCentral

38.

Yucel B, Eren AA, Erdis E et al (2013) Treatment results, side effects and prognostic factors affecting survival in patients with larynx cancer. J Med Updates 3:69–76CrossRef

39.

Pezier TF, Nixon IJ, Joshi A et al (2014) Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma. Eur Arch Otorhinolaryngol 271:2503–2509CrossRefPubMed

40.

Yousem DM, Gad K, Tufano RP (2006) Resectability issues with head and neck cancer. AJNR Am J Neuroradiol 27:2024–2036PubMed

41.

https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

42.

Beitler JJ, Muller S, Grist WJ et al (2010) Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol 28:2318–2322CrossRefPubMed

43.

Li B, Bobinski M, Gandour-Edwards R, Farwell DG, Chen AM (2011) Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation. Br J Radiol 84:64–69CrossRefPubMedPubMedCentral

44.

Skora T, Nowak-Sadzikowska J, Mucha-Malecka A et al (2015) Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors. Eur Arch Otorhinolaryngol 272:673–679CrossRefPubMed

45.

Lopez Delgado I, Riestra Ayora J, Arenas Britez O et al (2014) Salvage surgery for locoregional recurrences of advanced pharyngolaryngeal squamous cell carcinoma after organ preservation failure. Acta Otorhinolaryngol Ital 34:382–388PubMedPubMedCentral

46.

Bennett SH, Futrell JW, Roth JA, Hoye RC, Ketcham AS (1971) Prognostic significance of histologic host response in cancer of the larynx or hypopharynx. Cancer 28:1255–1265CrossRefPubMed

47.

Carter RL, Barr LC, O’Brien CJ, Soo KC, Shaw HJ (1985) Transcapsular spread of metastatic squamous cell carcinoma from cervical lymph nodes. Am J Surg 150:495–499CrossRefPubMed

48.

Brasilino de Carvalho M (1998) Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 20:16–21CrossRefPubMed

49.

Prabhu RS, Hamasoge S, Magliocca KR et al (2014) Extent of extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated initial surgical resection. Cancer 120:1499–1506CrossRefPubMed

50.

Spector GJ (2001) Distant metastases from laryngeal and hypopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec 63:224–228CrossRefPubMed

51.

Spector JG, Sessions DG, Haughey BH et al (2001) Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111:1079–1087CrossRefPubMed

52.

Yucel OT, Yilmaz T, Unal OF, Turan E (1999) Distant metastases in laryngeal squamous cell carcinoma. J Exp Clin Cancer Res 18:285–288PubMed

53.

Studer G, Lutolf UM, El-Bassiouni M, Rousson V, Glanzmann C (2007) Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol 46:386–394CrossRefPubMed

54.

Studer G, Glanzmann C (2013) Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT. Oral Oncol 49:269–276CrossRefPubMed

55.

Nikolaou A, Markou K, Petridis D, Vlachtsis K, Nalbantian M, Daniilidis L (2005) Factors influencing tumour relapse after total laryngectomy. B-ENT 1:1–10PubMed

Titel: Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol
verfasst von: Gorkem Eskiizmir
Gokce Tanyeri Toker
Onur Celik
Kivanc Gunhan
Ayca Tan
Hulya Ellidokuz
Publikationsdatum: 10.12.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 3/2017
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-016-4411-9

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol

Abstract

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach

Therapeutic efficacy of azithromycin and acetylcysteine in chronic otitis media with effusion

Effects of polymer-based, silver nanoparticle-coated silicone splints on the nasal mucosa of rats

Characteristics of cigarette smoking without alcohol consumption and laryngeal cancer: overall and time-risk relation. A meta-analysis of observational studies

Laser tracheobronchoplasty: a novel technique for the treatment of symptomatic tracheobronchomalacia

The role of laryngeal electromyography in vagus nerve stimulation-related vocal fold dysmotility

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO